Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v1-EN
Language English English
Date Updated 2020-04-20 2020-02-12
Drug Identification Number 02240205 02240205
Brand name COUMADIN TAB 3MG COUMADIN TAB 3MG
Common or Proper name Warfarin Warfarin
Company Name BRISTOL-MYERS SQUIBB CANADA BRISTOL-MYERS SQUIBB CANADA
Ingredients WARFARIN SODIUM WARFARIN SODIUM
Strength(s) 3MG 3MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1 BTL x 100 1 BTL x 100
ATC code B01AA B01AA
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Other (Please describe in comments) Delay in shipping of the drug.
Anticipated start date 2020-04-30 2020-04-30
Actual start date 2020-06-15
Estimated end date 2020-06-15 2020-06-15
Actual end date 2020-04-20
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments product discontinnued 4/20/202
Health Canada comments